IBS
Conditions
Interventions
None listed
Sponsors
Wageningen Universiteit
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * Aged 18 or older * Subjects must be able to understand the written study information and must be able to sign an informed consent * Subjects must be willing to collect faeces * Specifically for IBS: Rome III Criteria * Specifically for asymptomatic controls: no intestinal diseases in the colon
Exclusion criteria
Exclusion criteria: * Change in use of medication that may affect the intestinal microbiota, such as prebiotics, and laxatives * Recent use of probiotics (for at least one month before collection of the fecal samples) * Pre-exiting bowel diseases (such as inflammatory bowel disease or cancer) * Pregnancy/breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study outcome parameter is diversity and functionality of intestinal microbiota, which will be monitored every 1-2 months during a period of 6-12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Additional study parameters include quality of life, disease and treatment characteristics, and lifestyle factors including dietary intake, clinical patient history, family history, and demographics. | — |
Countries
Netherlands
Outcome results
None listed